New York, January 20, 2015 -- Moody's Investors Service said that HealthSouth Corporation's proposed offering of $300 million of senior unsecured notes due 2024 has no impact on its ratings, including the B1 (LGD 4) rating on the company's existing senior unsecured notes. Moody's understands that the proceeds of the offering, which is an add-on to the company's existing 5.75% senior notes due 2024, will be used to repay a portion of the company's senior secured term loan and revolver. HealthSouth's Ba3 Corporate Family Rating and Ba3-PD Probability of Default Ratings also remain unchanged given Moody's expectation that credit metrics will not be meaningfully impacted by this transaction. The stable rating outlook is also unchanged.

Vollständigen Artikel bei Moodys lesen